Severe COVID-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression: a case report
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread across the globe, leading to the declaration of a pandemic. While most present mild symptoms, it appears as though nearly 20% of confirmed patients develop significant complications. At this time of uncertainty, we a...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796834/ https://www.ncbi.nlm.nih.gov/pubmed/33456658 http://dx.doi.org/10.11604/pamj.supp.2020.37.1.25501 |
_version_ | 1783634763326685184 |
---|---|
author | Mounir, Louardi Mehdi, Simou Kawtar, Fahmaoui Akram, Mansour Youness, Et-tahir Meryem, Tabat Othmane, Joutey Tahiri Imane, Elkhaouri Hanane, Ezzouine Boubakar, Charra Marieme, Camara Mouna, Lamchahab Asmaa, Harrach Asmaa, Quessar |
author_facet | Mounir, Louardi Mehdi, Simou Kawtar, Fahmaoui Akram, Mansour Youness, Et-tahir Meryem, Tabat Othmane, Joutey Tahiri Imane, Elkhaouri Hanane, Ezzouine Boubakar, Charra Marieme, Camara Mouna, Lamchahab Asmaa, Harrach Asmaa, Quessar |
author_sort | Mounir, Louardi |
collection | PubMed |
description | The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread across the globe, leading to the declaration of a pandemic. While most present mild symptoms, it appears as though nearly 20% of confirmed patients develop significant complications. At this time of uncertainty, we are struggling to provide appropriate care to hematological cancer patients. We need to weigh the risks and benefits of giving cancer treatment against the odds of infecting them with COVID-19. As hematological cancer patients are immunocompromised and there are high chances of exposure during hospital visits, they can get infected and outcome can be fatal. So in this case report, we intend to discuss the possible impact of the current COVID-19 pandemic on patients with acute leukaemia in terms of diagnosis, chemotherapy, and prophylactic measures. |
format | Online Article Text |
id | pubmed-7796834 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The African Field Epidemiology Network |
record_format | MEDLINE/PubMed |
spelling | pubmed-77968342021-01-15 Severe COVID-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression: a case report Mounir, Louardi Mehdi, Simou Kawtar, Fahmaoui Akram, Mansour Youness, Et-tahir Meryem, Tabat Othmane, Joutey Tahiri Imane, Elkhaouri Hanane, Ezzouine Boubakar, Charra Marieme, Camara Mouna, Lamchahab Asmaa, Harrach Asmaa, Quessar Pan Afr Med J Case Report The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread across the globe, leading to the declaration of a pandemic. While most present mild symptoms, it appears as though nearly 20% of confirmed patients develop significant complications. At this time of uncertainty, we are struggling to provide appropriate care to hematological cancer patients. We need to weigh the risks and benefits of giving cancer treatment against the odds of infecting them with COVID-19. As hematological cancer patients are immunocompromised and there are high chances of exposure during hospital visits, they can get infected and outcome can be fatal. So in this case report, we intend to discuss the possible impact of the current COVID-19 pandemic on patients with acute leukaemia in terms of diagnosis, chemotherapy, and prophylactic measures. The African Field Epidemiology Network 2020-11-11 /pmc/articles/PMC7796834/ /pubmed/33456658 http://dx.doi.org/10.11604/pamj.supp.2020.37.1.25501 Text en Copyright: Louardi Mounir et al. https://creativecommons.org/licenses/by/4.0/The Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Mounir, Louardi Mehdi, Simou Kawtar, Fahmaoui Akram, Mansour Youness, Et-tahir Meryem, Tabat Othmane, Joutey Tahiri Imane, Elkhaouri Hanane, Ezzouine Boubakar, Charra Marieme, Camara Mouna, Lamchahab Asmaa, Harrach Asmaa, Quessar Severe COVID-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression: a case report |
title | Severe COVID-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression: a case report |
title_full | Severe COVID-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression: a case report |
title_fullStr | Severe COVID-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression: a case report |
title_full_unstemmed | Severe COVID-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression: a case report |
title_short | Severe COVID-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression: a case report |
title_sort | severe covid-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796834/ https://www.ncbi.nlm.nih.gov/pubmed/33456658 http://dx.doi.org/10.11604/pamj.supp.2020.37.1.25501 |
work_keys_str_mv | AT mounirlouardi severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport AT mehdisimou severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport AT kawtarfahmaoui severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport AT akrammansour severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport AT younessettahir severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport AT meryemtabat severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport AT othmanejouteytahiri severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport AT imaneelkhaouri severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport AT hananeezzouine severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport AT boubakarcharra severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport AT mariemecamara severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport AT mounalamchahab severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport AT asmaaharrach severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport AT asmaaquessar severecovid19infectioninapatientwithablastictransformationofachronicmyeloidleukemiaandseveretreatmentinducedimmunosuppressionacasereport |